Free Trial

Natixis Advisors LLC Makes New Investment in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Natixis Advisors LLC bought a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,247 shares of the health services provider's stock, valued at approximately $955,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Quadrature Capital Ltd acquired a new position in Maximus during the 1st quarter worth approximately $238,000. Price T Rowe Associates Inc. MD raised its stake in Maximus by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 38,100 shares of the health services provider's stock valued at $3,197,000 after buying an additional 2,322 shares in the last quarter. Bayesian Capital Management LP purchased a new stake in Maximus during the 1st quarter worth about $512,000. Tidal Investments LLC boosted its position in shares of Maximus by 238.9% during the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider's stock worth $1,071,000 after acquiring an additional 8,997 shares in the last quarter. Finally, Virtu Financial LLC boosted its position in shares of Maximus by 16.4% during the 1st quarter. Virtu Financial LLC now owns 3,610 shares of the health services provider's stock worth $303,000 after acquiring an additional 508 shares in the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Down 0.5 %

Shares of NYSE MMS traded down $0.39 during midday trading on Thursday, hitting $72.50. 1,701,725 shares of the company's stock were exchanged, compared to its average volume of 408,183. The firm's fifty day simple moving average is $87.17 and its 200-day simple moving average is $87.75. The company has a market cap of $4.37 billion, a PE ratio of 14.50 and a beta of 0.77. Maximus, Inc. has a twelve month low of $71.75 and a twelve month high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.66%. Maximus's dividend payout ratio (DPR) is presently 24.00%.

Insider Buying and Selling at Maximus

In other news, insider Michelle F. Link sold 1,363 shares of the firm's stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.40% of the stock is currently owned by insiders.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

→ AI breakthrough about to upend industry (From Porter & Company) (Ad)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines